Medicines

Health minister Andrew Little says the days of Pharmac prioritising the cheapest drugs possible over other considerations when making funding decisions are over

MĀORI, ASIAN AND PACIFIC peoples
are far less likely to be prescribed antidepressants
than New Zealand Europeans.

Pharmac welcomes the $191 million increase to its pharmaceutical budget over the next two years. It is already working its way through the medicines options for investment (OFI) list, looking at what agreements it can now make with pharmaceutical suppliers.

After a four-year hiatus, Medicines New Zealand has relaunched its annual Value of Medicines award, this time adding a new award for young scientists worth $30,000

Prescription drugs as well as common over-the-counter products have been hit by COVID-related supply issues on the other side of the world, Jonathan Chilton-Towle reports

Katrina Azer, a clinical pharmacist for Tend Health, looks at reasons why patients don’t take their medicines correctly and how health professionals can address it

Healthcare Handbook technical editor Carmen Fookes discusses the treatment of indigestion and heartburn

From next Thursday, a second oral COVID antiviral, molnupiravir, will be available for qualifying patients 

Global shipping delays, especially in China, are making it even more difficult to get medicines into New Zealand

An equity-focused Pharmac report on the prevalence of gout within Pacific communities is a commendable first step, says south Auckland GP and chair of the Pasifika GP Network Api Talemaitoga